Vivo Capital VIII, LLC - Significant Ownership

Signature - Title
Vivo Capital IX, LLC - Dr. Frank Kung, Managing Member
Location
Palo Alto, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Vivo Capital VIII, LLC.

Significant Ownership of Vivo Capital VIII, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SVA Sinovac Biotech Ltd. Common Shares, $0.001 par value per share 6.3% 4.54M Vivo Capital IX, LLC Apr 23, 2025

Schedules 13D/G Reported by Vivo Capital VIII, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.